# Perioperative FLOT vs Adjuvant XELOX for CA Stomach

> **NCT05264896** · PHASE3 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 110 (estimated)

## Conditions studied

- Cancer of Stomach, Adenocarcinoma

## Interventions

- **DRUG:** 5-FU, Leucovorin, Oxaliplatin, Docetaxel
- **DRUG:** XELOX

## Key facts

- **NCT ID:** NCT05264896
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-21
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264896, "Perioperative FLOT vs Adjuvant XELOX for CA Stomach". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05264896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*